Regeneron Pharmaceuticals
The Senior Manager, Translational Medicine Program Management provides program management support to cross-functional Translational Working Groups and leads program-agnostic initiatives. This role manages translational activities from preclinical research through post-marketing by driving the development and implementation of integrated Translational Medicine strategies, goals, timelines, and key deliverables. The position involves providing scientific and operational direction to R&D functions while ensuring cross-functional alignment across pipeline stages.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Head of Translational & Precision Medicine
USAJOBS
Associate Director, Global Biomarker Lead, Inflammation, GI2 TAU
BioLife Plasma Services
Head of Translational & Precision Medicine 1
USAJOBS
Vice President, Head of Translational Medicine and Translational Science
AstraZeneca
Director / Senior Director, Translational Medicine
Parexel
Director, Translational Medicine Expert (Neuromuscular)
Novartis